You can be on Entrepreneur’s cover!

'Pharma Bro' Martin Shkreli Arrested on Securities Fraud Charges The CEO of Turing Pharmaceuticals became infamous earlier this year when he drastically raised the price of a drug taken by AIDS patients.

By Geoffrey Smith

entrepreneur daily

This story originally appeared on Fortune Magazine

Getty Images
Martin Shkreli, the now-notorious CEO of Turing Pharmaceuticals.

Martin Shkreli, the now-notorious CEO of Turing Pharmaceuticals, has been arrested on suspicion of securities fraud, according to Bloomberg News.

Shkreli, 32, became infamous earlier this year when he drastically raised the price of a drug taken by AIDS patients, but Bloomberg said the case against him is unrelated to that.

Instead, prosecutors have charged him with illegally taking stock from Retrophin Inc., a biotech firm which he founded in 2011, and using it to pay off unrelated business debts, Bloomberg said.

Shkreli's hedge fund MSMB Capital Management suffered heavy losses as a result of the fraud, the agency added, referring also to allegations of "secret payoffs" and "sham consulting arrangements."

News Editor for Europe at Fortune.com.

Want to be an Entrepreneur Leadership Network contributor? Apply now to join.

Editor's Pick

Business News

From Tom Brady to Kevin O'Leary – See Who Lost Big in the Wake of the FTX Crypto Collapse

The crash exposed an $8 billion hole in FTX's accounts, leaving investors and customers scrambling to recoup their funds.

Business News

Mark Zuckerberg Says This CEO Is the 'Taylor Swift' of Tech

Meta's CEO posed with Nvidia CEO Jensen Huang on Instagram Wednesday.

Business News

This Highly-Debated Piece of Cinematic History Just Sold For Over $700,000 at Auction

The wood panel from "Titanic" is often mistaken as a door. Either way, he couldn't have fit. (Sorry.)

Money & Finance

5 Simple Wealth-Building Tips For This Generation's Forward-Thinkers

Explore practical finance tips for young professionals striving to overcome economic challenges.

Leadership

What We Have to Gain By Talking About Grief and Loss At Work

I lost my husband to cancer during Covid — here's how it changed how I lead at work.